Stock

Penumbra, Inc. PEN

$318.85+0.29%

All stocks Create account to unlock

Overview

PEN market data

Price History

PEN price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for PEN. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured

Penumbra Initiates FORWARD Trial To Collect Safety, Efficacy Data On Mechanical Thrombectomy · Jul 7, 2026, 1:20 PM

Evercore ISI Group Maintains Outperform on Penumbra, Lowers Price Target to $320 · Jul 6, 2026, 4:55 PM

GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT · Jul 6, 2026, 12:15 PM

Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider · Jun 19, 2026, 11:00 AM

RBC Capital Reiterates Sector Perform on Penumbra, Maintains $374 Price Target · Jun 12, 2026, 2:20 PM

Penumbra's THUNDERBOLT Gets FDA Clearance To Treat Acute Ischemic Stroke · Jun 11, 2026, 8:08 PM

8-K filing — Penumbra Inc (PEN) · May 6, 2026, 8:14 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock